PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'University Hospital of Strasbourg, France.\', \'Institut de Cancérologie Strasbourg Europe, Strasbourg, France.\', \'Paul Strauss Cancer Center, Strasbourg, France.\', \'LEAF4Life, Inc, Woburn, MA, USA.\', \'Platform of Integrative Chemical Biology of Strasbourg (PCBIS), UMS 3286 CNRS/University of Strasbourg, Illkirch-Graffenstaden, France; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France.\', \'Institut de Cancérologie Strasbourg Europe, Strasbourg, France; Paul Strauss Cancer Center, Strasbourg, France; Strasbourg Drug Discovery and Development Institute (IMS), Strasbourg, France. Electronic address: a.detappe@icans.eu.\', \'Institut de Cancérologie Strasbourg Europe, Strasbourg, France. Electronic address: x.pivot@icans.eu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0168-3659(21)00320-510.1016/j.jconrel.2021.06.033
?:hasPublicationType
?:journal
  • Journal of controlled release : official journal of the Controlled Release Society
is ?:pmid of
?:pmid
?:pmid
  • 34175365
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all